Endovia Health Sciences, Inc.
Limited financial coverage for EDVA.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Endovia Health Sciences is a diversified cannabinoid-based health sciences platform. The company's strategy focuses on three main areas: commercializing differentiated cannabinoid-based pharmaceutical products internationally, advancing cannabinoid-based human and veterinary therapeutics through U. S.
- CEO
- Brady Cobb
- IPO
- 2026
- Employees
- 2
- HQ
- Fort Lauderdale, FL, US
Get TickerSpark's AI analysis on EDVA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- 52W High
- $6.76
- 52W Low
- $0.13
- 50D MA
- $0.18
- 200D MA
- $0.82
- Beta
- -1.12
- RSI (14)
- 39
- Avg Volume
- 2.56M
No earnings-call transcripts are available for EDVA yet.
- Free Float
- —
- Shares Outstanding
- 6.41M
- Float Shares
- 6.41M
Held by 4 ETFs
Biggest fund positions in EDVA by dollar value.
Our EDVA coverage
Recent articles, reports, and earnings notes.
No research on EDVA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EDVA report →Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway
globenewswire.com · Oct 5
Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways
globenewswire.com · Sep 22
Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline
globenewswire.com · Aug 31
Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program
globenewswire.com · Aug 25
Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday
globenewswire.com · Aug 21
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.